Plastic Surgery Practice

Plastic Surgery Practice

Plastic Surgery Practice offers comprehensive insights into various procedures, treatment alternatives, practice management, and services within the aesthetics field. It connects with over 11,000 influential decision-makers and industry leaders. As a leading data company in healthcare, we help accelerate the acceptance of innovative trends, treatments, surgical tools, and practice management software within the sector.

National, Trade/B2B
English
Online/Digital

Outlet metrics

Domain Authority
46
Ranking

Global

#4788260

United States

#1980931

Health/Medicine

#8572

Traffic sources
Monthly visitors

Articles

  • 3 weeks ago | plasticsurgerypractice.com | Alyx Arnett

    Healthcare company Organon announced results from an analysis of its Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA (tapinarof) cream, 1% once daily for treatment in adults and children 2 years of age and older with atopic dermatitis (AD), also known as eczema. The findings demonstrate that AD disease activity remained mild in patients who had achieved treatment success and subsequently entered a treatment-free interval lasting on average 80 days.

  • 3 weeks ago | plasticsurgerypractice.com | Alyx Arnett

    Health Canada has approved the use of Radiesse, a biostimulatory dermal filler, for the treatment of moderate wrinkles in the décolleté area. The regulatory milestone expands the product's approved uses in Canada beyond the face and hands. Radiesse, developed by Merz Aesthetics, is designed to stimulate the body's natural collagen and elastin production.

  • 3 weeks ago | plasticsurgerypractice.com | Alyx Arnett

    Rion Aesthetics announced that the US Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) application to proceed for a phase 1 investigator-initiated trial evaluating Purified Exosome Product (PEP) injected into the dermis. The study is sponsored and independently conducted by Clinical Testing Center of Beverly Hills and is being led by John H. Joseph, MD, a double board-certified facial plastic surgeon based in California.

  • 3 weeks ago | plasticsurgerypractice.com | Alyx Arnett

    CollPlant Biotechnologies, a regenerative and aesthetic medicine company, announced that the European Patent Office has allowed a patent application related to the company's injectable fillers and regenerative breast implant candidates. The technologies are being developed for use in aesthetic and reconstructive procedures. The newly allowed patent application covers CollPlant's soft tissue fillers and its organ manufacturing technology associated with its regenerative breast implant pipeline.

  • 3 weeks ago | plasticsurgerypractice.com | Alison Werner

    Guidepoint Qsight's Erik Haines breaks down the drivers behind 2024's $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry. As the demand for aesthetic treatments continues to evolve, new data from Guidepoint Qsight reveals key trends shaping the future of non-surgical care.

Plastic Surgery Practice journalists

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations